Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00688025 · ClinicalTrials.gov registry record
Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 24
- Enrollment target
NCT00688025 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 24 participants.
The verdict
NCT00688025 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The present protocol will utilize simultaneous recording of brain activity during attention and memory tasks in insomnia participants after ramelteon vs. zolpidem vs. placebo administration. The investigators hypothesize that amplitudes of associated with memory will be unchanged by ramelteon, whereas zolpidem will significantly reduce brain activity associated with stimulus processing as evidenced by abnormal reduction in the amplitude of specific brain regions relative to placebo.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00688025
The ClinicalTrials.gov registry entry for NCT00688025 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00688025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00688025 about?
NCT00688025 is a clinical study titled "Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia". The present protocol will utilize simultaneous recording of brain activity during attention and memory tasks in insomnia participants after ramelteon vs. zolpidem vs. placebo administration. The investigators hypothesize that amplitudes of associated with memory will be unchanged by ramelteon, where...
What is the current status of trial NCT00688025?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2008-05. Estimated completion is 2010-03.
Who is sponsoring clinical trial NCT00688025?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.